04.30.19
The newly appointed Supervisory Board of Merck KGaA, Darmstadt, Germany, re-elected Wolfgang Büchele as its chairman following the 24th Annual General Meeting. Michael Fletterich was also confirmed as vice chairman, representing the employee side.
Apart from Büchele, five further shareholder representatives were elected by shareholders at the Annual General Meeting in Frankfurt am Main. Moreover, two shareholder representatives were directly appointed by E. Merck KG, Darmstadt, Germany. The eight-employee representative members had already been elected on April 11. The Supervisory Board members are appointed for the period until the end of the Annual General Meeting 2024.
The new Supervisory Board of Merck KGaA, Darmstadt, Germany, consists of the following members: Dr. Wolfgang Büchele (chairman), Michael Fletterich (vice chairman), Dr. Gabriele Eismann, Edeltraud Glänzer, Jürgen Glaser, Sascha Held, Michael Kleinemeier, Renate Koehler, Anne Lange, Peter Emanuel Merck, Dr. Dietmar Oeter, Dr. Christian Raabe, Helene von Roeder, Prof. Dr. Helga Rübsamen-Schaeff, Dr. Daniel Thelen, and Dr. Simon Thelen.
In addition, the Annual General Meeting approved the actions of the Executive Board and the Supervisory Board of Merck KGaA for fiscal 2018 by a large majority and approved all of the resolutions.
Apart from Büchele, five further shareholder representatives were elected by shareholders at the Annual General Meeting in Frankfurt am Main. Moreover, two shareholder representatives were directly appointed by E. Merck KG, Darmstadt, Germany. The eight-employee representative members had already been elected on April 11. The Supervisory Board members are appointed for the period until the end of the Annual General Meeting 2024.
The new Supervisory Board of Merck KGaA, Darmstadt, Germany, consists of the following members: Dr. Wolfgang Büchele (chairman), Michael Fletterich (vice chairman), Dr. Gabriele Eismann, Edeltraud Glänzer, Jürgen Glaser, Sascha Held, Michael Kleinemeier, Renate Koehler, Anne Lange, Peter Emanuel Merck, Dr. Dietmar Oeter, Dr. Christian Raabe, Helene von Roeder, Prof. Dr. Helga Rübsamen-Schaeff, Dr. Daniel Thelen, and Dr. Simon Thelen.
In addition, the Annual General Meeting approved the actions of the Executive Board and the Supervisory Board of Merck KGaA for fiscal 2018 by a large majority and approved all of the resolutions.